Zscaler Adam Geller exercises options, sells 1,041 shares

Adam Geller's reported option position after the exercise was 23,959 shares, and the stock sale followed a plan adopted on March 20, 2026.

Available on EDGAR 11/03/2026 - 05:02 PM EST Accepted by SEC EDGAR 11/03/2026 - 05:01 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Zscaler, Inc. (ZS) Chief Product Officer Adam Geller exercised fully vested, immediately exercisable options covering 1,041 common shares on November 2, 2026, at an exercise price of $205.61 per share, then sold 1,041 shares at $238.00 per share. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 20, 2026. His reported option position after the exercise was 23,959 shares.

Insider Trade Summary 10b5-1

Exercise and Sale: 1,041 shares ($34K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider Geller Adam

Role Chief Product Officer

Sold 1,041 shs ($248K)

Approx. gross sale proceeds $248K

Approx. exercise cost $214K

Approx. pre-tax spread $34K

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy) F2	1,041	$205.61	$214K
Exercise	Common Stock	1,041	$205.61	$214K
Sale	Common Stock F1	1,041	$238.00	$248K

Holdings After Transaction: Stock Option (right to buy) — 23,959 contracts (Direct); Common Stock — 58,167 shares (Direct)

Footnotes (2)

1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on March 20, 2026.
2. F2. The shares subject to the options are fully vested and immediately exercisable.

Key Figures

Options exercised: 1,041 shares Option exercise price: $205.61 per share Shares sold: 1,041 shares +2 more

5 metrics

Options exercised 1,041 shares November 2, 2026

Option exercise price $205.61 per share November 2, 2026

Shares sold 1,041 shares November 2, 2026

Sale price $238.00 per share November 2, 2026

Option shares following exercise 23,959 shares Reported after the November 2, 2026 exercise

Key Terms

Rule 10b5-1 trading plan, fully vested, immediately exercisable

3 terms

Rule 10b5-1 trading plan regulatory

"the sale was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

fully vested technical

"the options are fully vested"

immediately exercisable technical

"the options are immediately exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZS shares did Adam Geller exercise and sell?

Adam Geller exercised options covering 1,041 Zscaler common shares at $205.61 per share on November 2, 2026, then sold 1,041 shares at $238.00 per share that day. His reported option position after the exercise was 23,959 shares.

Was Adam Geller's ZS stock sale made under a trading plan?

Yes. The sale of 1,041 shares on November 2, 2026, was effected pursuant to a Rule 10b5-1 trading plan adopted on March 20, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geller Adam

(Last) (First) (Middle)

4401 GREAT AMERICA PARKWAY

(Street)

SANTA CLARA CALIFORNIA 95054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zscaler, Inc. [ ZS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Product Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/02/2026		M		1,041	A	$205.61	59,208	D
Common Stock	11/02/2026		S(1)		1,041	D	$238	58,167	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$205.61	11/02/2026		M			1,041	(2)	12/05/2034	Common Stock	1,041	$205.61	23,959	D

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on March 20, 2026.

2. The shares subject to the options are fully vested and immediately exercisable.

Remarks:

	/s/ Torrie Nute, by power of attorney	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)